Systolic Pressure Best Indicator Of Heart Disease In Hypertensive Men
Systolic blood pressure (SBP) is a good indicator of cardiovascular disease and coronary heart disease in hypertensive men being treated in clinical […]
Thoratec Gets European Okay for IVAD Heart Pump
CHICAGO (Reuters) – Cardiovascular device maker Thoratec Corp. said on Monday it has received European marketing approval for the Thoratec IVAD, an […]
VE LVAS for End-Stage Heart Failure
Abstract The HeartMate Vented Electric Left Ventricular Assist System (LVAS) is an implantable cardiac assist device for end-stage congestive heart failure. The […]
Medicare to Expand Heart Pump Coverage
Proposed Medicare rules would add 30% to coverage for Thoratec Corp.’s heart-assist device. Thoratec said the proposed rules would reimburse the company’s […]
Recent Advancements in the Management of Heparin-Induced Thrombocytopenia
Article orginally published in March 1998 Theodore E. Warkentin,MD, FRCPC, FACP Guest EditorHamilton Health Sciences Corporation and McMaster UniversityHamilton, Ontario, Canada Thrombocytopenia […]
Drug-Induced Thrombocytopenia: A Systematic Review of Published Case Reports
Annals of Internal Medicine, 1 December 1998. 129:886-890. James N. George, MD; Gary E. Raskob, MSc; Shehla Rizvi Shah, MD; Mujahid A. […]
Thrombospondin Gene Variants Associated With familial Premature CAD
Multiple novel variants in the thrombospondin gene family appear to be associated with familial premature coronary artery disease, investigators report in a […]
Outcomes After TMR Are Poor for Some Patients
Diabetics and patients with a preoperative body mass index of less than 25 have worse 1-year outcomes after transmyocardial laser revascularization (TMR) […]
TMR Tied to Increased 5-Year Survival in “No-Option” Angina Patients
Previous reports have shown that transmyocardial revascularization (TMR) can provide many short-term benefits for class IV angina patients who are not candidates […]
Washington Hospital Center Performs First TMR Surgery With PLC Systems’ Next-Generation CO2 Heart Laser 2(TM)
PLC Systems Inc. (Amex: PLC), the leader in carbon dioxide (CO2) transmyocardial revascularization (TMR), announced that on March 12, 2001, Dr. Stephen […]
Transmyocardial Laser Therapy: A Strategic Approach
Background: Coronary artery bypass and percutaneous intervention have become the established methods of coronary revascularization in treating angina pectoris. Subsets of angina […]
Laser Surgery Halts Chest Pain Over The Long-Term
NEW ORLEANS, LA — November 15, 2000 — In one of the largest studies to date, researchers have shown that transmyocardial revascularization, […]